Human lung cancer cell lines (A549) were treated with wogonin (0, 5, 15, or 20 μmol/L), and it was found that wogonin significantly improved caspase‐3, downregulated Bcl‐2, and reduced ErbB4 expression. This evidence concerns the gene BCL2 and lung cancer.